Acuitas Therapeutics at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Acuitas Therapeutics takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its program centres on lipid nanoparticles (LNPs), the carriers that deliver mRNA vaccines. The session covers next-generation LNPs designed to improve how mRNA vaccines perform.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Acuitas Therapeutics
Vancouver, Canada
acuitastx.com
BiotechShowcase sponsor
Develops lipid nanoparticle (LNP) delivery systems for mRNA vaccines and therapeutics, licensed to partner companies.
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 20
14:15
Next-Generation LNP: Advancing mRNA Vaccine Performance
Pre-Clinical Development

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Acuitas Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction